Takeda Pharmaceutical Co Ltd 2022 IR
The report highlights Takeda's financial and non-financial performance for the fiscal year ended March 31, 2022, emphasizing its commitment to patients, people, and the planet. Takeda achieved carbon neutrality across its value chain in 2020 and committed to reaching net-zero greenhouse gas emissions in its operations before 2035 and across its entire value chain before 2040. The company reported a 27% reduction in greenhouse gas emissions from its direct operations compared to a FY2016 baseline. Financially, Takeda delivered a strong performance with revenue of 3,569.0 billion yen, representing an 11.6% year-on-year increase, driven by its global growth and launch products.
Company: Takeda Pharmaceutical Co Ltd
Sector: Health Care
Country: Japan
Year: 2022
Type: IR
Pages: 75
Takeda Pharmaceutical Co Ltd
Annual Integrated Report
The report highlights Takeda's financial and non-financial performance for the fiscal year ended March 31, 2022, emphasizing its commitment to patients, people, and the planet. Takeda achieved carbon neutrality across its value chain in 2020 and committed to reaching net-zero greenhouse gas emissions in its operations before 2035 and across its entire value chain before 2040. The company reported a 27% reduction in greenhouse gas emissions from its direct operations compared to a FY2016 baseline. Financially, Takeda delivered a strong performance with revenue of 3,569.0 billion yen, representing an 11.6% year-on-year increase, driven by its global growth and launch products.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2022
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women in Management
Net Zero Target
Employees